|Articles|January 22, 2010

Medical Economics, Digital Edition, January 22nd, 2010

Stay informed with the Medical Economics eNewsletter, delivering expert insights, financial strategies, practice management tips, and technology trends tailored for today’s physicians.

Latest CME

Video

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Video

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Jordan Axelrad, MD, MPH, FACG, FCCF; Jessica R. Allegretti, MD, MPH; Florian Rieder, MD

Medical Economics, Digital Edition, January 22nd, 2010

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Trending on Medical Economics

Primary care cuts the financial and human cost of chronic disease. So why isn’t the nation investing in it?

Lifestyle medicine could be direct primary care's next differentiator, whitepaper says

Physicians have 5 responsibilities that AI will not replace: AMA

AAFP issues fall vaccine recommendations amid competing guidance

McKesson data breach exposes prescribing physicians and their patients to fallout from a third-party attack